<DOC>
	<DOCNO>NCT01112462</DOCNO>
	<brief_summary>This study design assess bioequivalence two paracetamol/ phenylephrine combination product .</brief_summary>
	<brief_title>To Test Bioequivalence Between Two Formulations Paracetamol/Phenylephrine</brief_title>
	<detailed_description>The study single dose , randomize , two-way crossover study 40 healthy subject , equal number male female . Drop-outs replace . The two dos medication give study ( single dose two study period ) separate washout period least 7 day . In study period , sixteen blood sample pharmacokinetic analysis take 24 hour . Blood sample centrifuge concentration paracetamol phenylephrine plasma measure use validated chromatographic assay . Pharmacokinetic parameter calculate plasma concentration data . The rate extent absorption formulation compare .</detailed_description>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Healthy male female Caucasians Aged 18 50 year BMI â‰¤ 30 kg/m2 Clinically normal medical history Physical normal examination Normal laboratory test result Pregnancy , lactation intend pregnancy Hypersensitivity intolerant study medication Donation loss blood within 90 day precede first dose study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Nasal congestion , Headache</keyword>
</DOC>